Back

The impact of APOC3 and APOE gene polymorphisms on response to statin therapy in acute myocardial infarction.

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Marina Teterina

PFUR, Vilnius (Lithuania)

16 More presentations in this session

Presentation thumbnail
Doctor K. Svendsen (Oslo, NO)
Abstract Slides
Presentation thumbnail
Doctor R. CHEN (Beijing, CN)
Abstract Slides
Presentation thumbnail
Associate Professor K. Dyrbus (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Doctor A. Mahabadi (Essen, DE)
Abstract
Presentation thumbnail
Doctor C. Kissel (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease
28 August 2020
thumbnail
Congress Presentation
High apo-CIII level correlates with poor lipid status, pro-inflammatory and fibrotic biomarker profile, and adverse cardiovascular outcome in patients with recent acute coronary syndrome
30 August 2025
thumbnail
Congress Presentation
Apolipoprotein E4 a possible genetic risk factor for heart failure
29 June 2021
thumbnail
Congress Presentation
The optimization of dual antiplatelet therapy in patients with ST-segment elevation myocardial infarction in dependence on the vasculoendothelial growth factor-A gene polymorphism G634C (rs2010963)
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources